Manganese‐induced parkinsonism responsive to intranasal insulin: A case report
Abstract Here, we introduced a patient with Mn‐induced parkinsonism who was responsive to intranasal insulin, and his parkinsonism and dystonia responded to this treatment.
Main Authors: | Mehri Salari, Masoud Etemadifar, Leila Dargahi, Neda Valian, Malihe Rezaee |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-03-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.5562 |
Similar Items
-
The hidden obstacles to intranasal insulin delivery: A narrative review
by: Ujjawal Rawat, et al.
Published: (2023-01-01) -
Severity of parkinsonism associated with environmental manganese exposure
by: Brad A. Racette, et al.
Published: (2021-03-01) -
Optimization of Pramipexole-Loaded In Situ Thermosensitive Intranasal Gel for Parkinson’s Disease
by: Rushi Trivedi, et al.
Published: (2024-01-01) -
Hydrogen bond-enhanced nanogel delivery system for potential intranasal therapy of Parkinson's disease
by: Yi-Bing Chen, et al.
Published: (2022-07-01) -
Odor Sensitivity After Intranasal Insulin Application Is Modulated by Gender
by: Rea Rodriguez-Raecke, et al.
Published: (2018-10-01)